会议专题

Methylenetetrahydrofolate reductase C677T polymorphism predicts response and time to progression(TTP) to gemcitabine-based chemotherapy in advanced non-small cell lung cancer in a Chinese Han population

Wei Hong Xiao-Jian Wang Kai Wang Yi-Ping Zhang Jun-yan Kou Dan Hong Dan Su Wei-min Mao Xin-min Yu Fa-jun Xie

Department of Medical Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, Zhejiang,China;Zhejiang k Institute of Immunology, Zhejiang University School of Medicine, Hangzhou 310058, Zhejiang, China Department of Respiratory Medicine, Second Affiliated Hospital, Medical School of Zhejiang Universit Department of Medical Oncology, Hangzhou Cancer Hospital, Hangzhou 310002, Zhejiang, China Zhejiang key laboratory of the diagnosis & treatment technology on thoracic oncology,Hangzhou 310022

国内会议

第十五届全国临床肿瘤学大会暨2012年CSCO学术年会

北京

英文

11-12

2012-09-19(万方平台首次上网日期,不代表论文的发表时间)